Switch theme
Sign up to access all valuation multiples
Paxman AB is a Sweden based company engaged in the development of PAXMAN Scalp Cooling System that is used to minimize hair loss in connection with chemotherapy treatment. The company offers a stand-alone, mobile electric cooling unit, which is a liquid-based cooling system that cools down the patient's scalp through the silicone hat. Geographically the company markets its product to Great Britain, Scandinavian countries, the Netherlands, Belgium, and Australia.
2016
91
LTM Revenue $29.7M
LTM EBITDA $6.5M
$121M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Paxman has a last 12-month revenue of $29.7M and a last 12-month EBITDA of $6.5M.
In the most recent fiscal year, Paxman achieved revenue of $25.1M and an EBITDA of $4.9M.
Paxman expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Paxman valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $20.9M | $25.1M | XXX | XXX | XXX |
| Gross Profit | $10.1M | $14.5M | XXX | XXX | XXX |
| Gross Margin | 48% | 58% | XXX | XXX | XXX |
| EBITDA | $3.1M | $4.9M | XXX | XXX | XXX |
| EBITDA Margin | 15% | 20% | XXX | XXX | XXX |
| Net Profit | -$1.0M | $0.8M | XXX | XXX | XXX |
| Net Margin | -5% | 3% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Paxman's stock price is SEK 66 (or $7).
Paxman has current market cap of SEK 1.2B (or $124M), and EV of SEK 1.2B (or $121M).
See Paxman trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $121M | $124M | XXX | XXX | XXX | XXX | $0.25 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Paxman has market cap of $124M and EV of $121M.
Paxman's trades at 4.1x LTM EV/Revenue multiple, and 18.8x LTM EBITDA.
Analysts estimate Paxman's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Paxman and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $121M | XXX | XXX | XXX |
| EV/Revenue | 4.8x | XXX | XXX | XXX |
| EV/EBITDA | 24.6x | XXX | XXX | XXX |
| P/E | 31.0x | XXX | XXX | XXX |
| P/E/Growth | 0.4x | XXX | XXX | XXX |
| EV/FCF | 76.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPaxman's NTM/LTM revenue growth is 47%
Paxman's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Paxman's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Paxman's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Paxman and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 20% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 59% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 67% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 56% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Paxman acquired XXX companies to date.
Last acquisition by Paxman was XXXXXXXX, XXXXX XXXXX XXXXXX . Paxman acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Paxman founded? | Paxman was founded in 2016. |
| Where is Paxman headquartered? | Paxman is headquartered in Sweden. |
| How many employees does Paxman have? | As of today, Paxman has 91 employees. |
| Is Paxman publicy listed? | Yes, Paxman is a public company listed on STO. |
| What is the stock symbol of Paxman? | Paxman trades under PAX ticker. |
| When did Paxman go public? | Paxman went public in 2017. |
| Who are competitors of Paxman? | Similar companies to Paxman include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Paxman? | Paxman's current market cap is $124M |
| What is the current revenue of Paxman? | Paxman's last 12-month revenue is $29.7M. |
| What is the current EBITDA of Paxman? | Paxman's last 12-month EBITDA is $6.5M. |
| What is the current EV/Revenue multiple of Paxman? | Current revenue multiple of Paxman is 4.1x. |
| What is the current EV/EBITDA multiple of Paxman? | Current EBITDA multiple of Paxman is 18.8x. |
| What is the current revenue growth of Paxman? | Paxman revenue growth between 2023 and 2024 was 20%. |
| Is Paxman profitable? | Yes, Paxman is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
